AbbVie Inc. (NYSE:ABBV) ranks among the top picks for a retirement portfolio. The FDA received a New Drug Application from ...

A South Korean research group has reported in a new paper that artificial intelligence and light-based genetic tools can work together to diagnose and stop Parkinson’s-like disease in mice. The work ...

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...

In a landmark discovery, scientists from the University of Cambridge and University College London have, for the first time, ...

Researchers at the University of Bath, in collaboration with the Universities of Oxford and Bristol, have developed a ...

Tavapadon is an investigational, novel, once-daily treatment option for Parkinson’s disease, which currently affects more ...

For more than a decade, Carnegie Mellon neuroscientist Aryn Gittis has been unraveling the mystery of how the brain controls movement — research now pointing toward new treatments for Parkinson’s ...

Globally recognized figures Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease presents ...

It's a test of CEO Bill Anderson's development credentials as patent expiries on blockbuster drugs threaten the group's ...

The toxins could potentially be used as ‘markers’ for doctors to identify Parkinson’s patients at a higher risk of developing dementia ...

Globally recognized figures like Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease ...

Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, announced the successful ...